For the quarter ending 2026-03-31, GANX has $18,738,464 in assets. $4,731,487 in debts. $16,539,222 in cash and cash equivalents.
| Balance Sheets | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 |
|---|---|---|---|---|
| Cash and cash equivalents | 16,539,222 | 20,837,628 | 8,807,353 | 6,694,136 |
| Tax credits | 231,003 | 179,701 | 271,515 | 317,844 |
| Prepaid expenses and other current assets | 1,451,543 | 1,219,809 | 1,438,400 | 2,294,723 |
| Total current assets | 18,221,768 | 22,237,138 | 10,517,268 | 9,306,703 |
| Property and equipment, net | 54,435 | 74,916 | 85,572 | 96,190 |
| Internal-use software, net | 90,045 | 102,837 | 114,607 | 127,857 |
| Operating lease right-of-use assets | 300,576 | 334,090 | 184,422 | 233,200 |
| Restricted cash | 36,085 | 36,296 | 36,117 | 36,278 |
| Long-term deposits and other noncurrent assets | 35,555 | 33,698 | 33,694 | 33,752 |
| Total noncurrent assets | 516,696 | 581,837 | 454,412 | 527,277 |
| Total assets | 18,738,464 | 22,818,975 | 10,971,680 | 9,833,980 |
| Deferred grant income - current | - | - | 11,293 | 22,685 |
| Accounts payable | 1,516,362 | 825,027 | 1,577,151 | 2,713,013 |
| Operating lease liabilities - current | 116,627 | 119,876 | 115,910 | 136,320 |
| Other current liabilities | 2,153,304 | 2,306,624 | 2,340,703 | 2,198,918 |
| Loans - current | 100,281 | 100,869 | 125,545 | 126,108 |
| Total current liabilities | 3,886,574 | 3,352,396 | 4,170,602 | 5,197,044 |
| Defined benefit pension plan | 389,519 | 390,509 | 527,825 | 522,676 |
| Operating lease liabilities - noncurrent | 182,129 | 211,238 | 65,026 | 92,851 |
| Loans - noncurrent | 273,265 | 300,084 | 298,797 | 325,359 |
| Total noncurrent liabilities | 844,913 | 901,831 | 891,648 | 940,886 |
| Total liabilities | 4,731,487 | 4,254,227 | 5,062,250 | 6,137,930 |
| Common stock, 0.0001 par value 100,000,000 shares authorized 42,488,578 and 42,073,807 shares issued and outstanding as of march 31, 2026 and december 31, 2025, respectively | 4,250 | 4,209 | 3,599 | 3,078 |
| Additional paid-in capital | 119,970,514 | 119,139,677 | 102,161,036 | 94,642,942 |
| Accumulated other comprehensive income | 996,952 | 776,869 | 563,221 | 584,083 |
| Accumulated deficit | -101,356,007 | -81,194,908 | -81,194,908 | -81,194,908 |
| Loss of the period | -5,608,732 | -20,161,099 | -15,623,518 | -10,339,145 |
| Total stockholders' equity | 14,006,977 | 18,564,748 | 5,909,430 | 3,696,050 |
| Total liabilities and stockholders' equity | 18,738,464 | 22,818,975 | 10,971,680 | 9,833,980 |
Gain Therapeutics, Inc. (GANX)
Gain Therapeutics, Inc. (GANX)